Skip to content
Youtube
Linkedin
(888) 734-9778
Blog
News & Events
Videos
Resources
Blog
News & Events
Videos
Resources
Youtube
Linkedin
(888) 734-9778
Home
About Us
Senior Staff
Why Us
Mission And Vision
Clients
Career Opportunities
Services
Inspection Readiness & Enforcement
FDA Inspection Readiness
Audits & Assessments
FDA Enforcement Response / Remediation
FDA Quality Consulting
Quality System Restructuring*
Training / Coaching
External Supply Chain Quality
Quality Data, Part 11 & CSV*
Quality Assurance & Engineering
Product Quality Consulting
Efficiency & Compliance*
Project / Program Management
FDA Regulatory Consulting
Development & Launch Support*
Mergers / Acquisitions / Licensing
Clinical Study Consulting Services
Clinical Compliance
Keep Your Clinical Studies on Track with Compliance Architects
Data Services, Business Intelligence, EQMS
Data Services, eQMS & BI
Innovative Solutions
Writing for Compliance®
CRPN Quality Roadmap®
Quality Pulse®
Success Stories
Industries
Pharmaceuticals
Medical Devices and Diagnostics
Biopharmaceuticals
Syringe
Created with Sketch.
Combination Products
Dietary Supplements
Cell & Gene Therapies
Cosmetics
Cannabis / CBD
Contact Us
X
Home
About Us
Senior Staff
Why Us
Mission And Vision
Clients
Career Opportunities
Services
Innovative Solutions
Writing for Compliance®
CRPN Quality Roadmap®
Quality Pulse®
Success Stories
Industries
Blog
News & Events
Videos
Resources
Contact Us
X
Essential Tools for Compliance Success
Resources
eBook
21 CFR 117
21 CFR 117 – CURRENT GOOD MANUFACTURING PRACTICE, HAZARD ANALYSIS, AND RISK-BASED PREVENTIVE CONTROLS FOR HUMAN FOOD
Prev
Previous
Managed Service Solution for Pharmaceutical Annual Product Review (APR)
Next
6 Reasons to Work with Interim Expert Placement Firms
Next
Free Online Training
Related Resources:
Navigate FDA Warning Letters: 4 Main Causes from John Daley
6 Reasons to Work with Interim Expert Placement Firms
21 CFR 117
